A comparison of international modelling methods to evaluate health economics of colorectal cancer screening: a systematic review

Olivia Adair*, Ethna McFerran, Felicity Lamrock, Mark Lawler, Richard Fallis

*Corresponding author for this work

Research output: Other contribution

Abstract

Colorectal cancer (CRC) is the second most common cancer in females and the third most common cancer in males throughout the world [1]. However, this can be prevented through early diagnosis via screening. Although extremely beneficial to the public, screening and the subsequent path leading from this can be costly. In 2015, it was found that across Europe, colorectal cancer had cost 19.1 billion (Euros) to the economy [2]. Therefore, it is important that the most cost-effective approach to CRC screening is taken to maximise the survival outcomes from policy choices.

This review will identify different cost-effectiveness modelling methods to evaluate the health economics of colorectal cancer which are used internationally, in order to use this information to examine the key attributes of a cost-effectiveness model and support the use of findings in future to build more efficient models, grounded in real-world data for application in screening programmes worldwide.
Original languageEnglish
TypeSystematic Review Protocol Registraton
Media of outputPROSPERO Online Database
Publication statusPublished - 11 Jan 2022

Fingerprint

Dive into the research topics of 'A comparison of international modelling methods to evaluate health economics of colorectal cancer screening: a systematic review'. Together they form a unique fingerprint.

Cite this